GLPBio

PKC

PKC (protein kinase C) is a serine/threonine protein kinase that mediates insulin signaling, actin cytoskeleton, cell mobility, apoptosis and tumorigenesis etc.

Products Related to PKC(146)

  • GC16934 structure
    GC16934Valrubicin
    CAS: 56124-62-0
    Purity: >99.50%

    chemotherapy drug used to treat bladder cancer

  • GC17014 structure
    GC17014Ro 31-8220 Mesylate
    CAS: 138489-18-6

    Pan-PKC inhibitor

  • GC17239 structure
    GC17239Bisindolylmaleimide V
    CAS: 113963-68-1
    Purity: >98%

    negative control for protein kinase C (PKC)-inhibitory activity

  • GC17242 structure
    GC17242(-)-epigallocatechin
    CAS: 970-74-1
    Purity: >98.00%

    (-)-epigallocatechin is a major polyphenolic compound in green tea with antioxidant properties.

  • GC17346 structure
    GC17346KT 5823
    CAS: 126643-37-6
    Purity: >95.00%

    A protein kinase G inhibitor

  • GC17352 structure
    GC17352Phorbol 12,13-dibutyrate
    CAS: 37558-16-0
    Purity: >99.50%

    Protein kinase C activator

  • GC17563 structure
    GC17563LY 333531 hydrochloride
    CAS: 169939-93-9
    Purity: >98.00%

    Ruboxistaurin (LY333531) hydrochloride is an orally active, selective PKC beta inhibitor (Ki=2 nM).

  • GC17591 structure
    GC17591D-erythro-Sphingosine (synthetic)
    CAS: 123-78-4
    Purity: >98.00%

    D-erythro-Sphingosine (synthetic) is a bioactive activator of p32 kinase (EC 50 =8μM).

  • GC17670 structure
    GC17670Bryostatin 1
    CAS: 83314-01-6
    Purity: >99.00%

    PKC activator

  • GC17727 structure
    GC17727[Ala107]-MBP (104-118)
    CAS: 99026-77-4
    Purity: >98%

    Non-competitive inhibitor of PKC

  • GC17767 structure
    GC17767Dihydrosphingosine
    CAS: 3102-56-5
    Purity: >98%

    Dihydrosphingosine is a potent inhibitor of PKC and phospholipase A2 (PLA2).

  • GC17815 structure
    GC17815L-threo-Sphingosine C-18
    CAS: 25695-95-8
    Purity: >98%

    L-threo-Sphingosine C-18 is a potent MAPK inhibitor. L-threo-Sphingosine C-18 induces apoptosis and clear DNA fragmentation. L-threo-Sphingosine C-18 shows anticancer effect.

  • GC18055 structure
    GC18055SC-9
    CAS: 102649-78-5
    Purity: >98%

    protein kinase C activator

  • GC18062 structure
    GC180621,2-Dilauroyl-sn-glycerol
    CAS: 60562-15-4
    Purity: >98%

    A longchain DAG

  • GC18246 structure
    GC18246R-59-949
    CAS: 120166-69-0
    Purity: >98.00%

    R-59-949 is an inhibitor of diacylglycerol kinase α (DGK-α) with an IC50 value of 300 nM in isolated platelet plasma membranes using exogenous diacylglycerol as a substrate.

  • GC18354 structure
    GC18354Bisindolylmaleimide X (hydrochloride)
    CAS: 145317-11-9
    Purity: >98.50%

    Bisindolylmaleimide X (hydrochloride) is a novel, cell-permeable protein kinase C (PKC) inhibitor. Bisindolylmaleimide X also inhibits cyclin-dependent kinase 2 (CDK2) activity.

  • GC18521 structure
    GC18521Cercosporin
    CAS: 35082-49-6
    Purity: >95.00%

    Cercosporin is a pigmented phytotoxin isolated from the fungus C.

  • GC25662 structure
    GC25662N-Desmethyltamoxifen
    CAS: 31750-48-8
    Purity: >98%

    N-Desmethyltamoxifen, the major metabolite of Tamoxifen in humans and a ten-fold more potent protein kinase C (PKC) inhibitor than Tamoxifen, also is a potent regulator of ceramide metabolism in human AML cells, limiting ceramide glycosylation, hydrolysis, and sphingosine phosphorylation.

  • GC26055 structure
    GC26055WAY-301398
    CAS: 312607-68-4
    Purity: >98%

    WAY-301398 (6-methoxynaphthalene) can bind to protein kinase C (PKC).

  • GC26065 structure
    GC26065WAY-354831
    CAS: 330572-32-2
    Purity: >98%

    WAY-354831 exhibits antibacterial activity.

  • GC30200 structure
    GC30200PKC-theta inhibitor
    CAS: 736048-65-0
    Purity: >99.50%

    PKC-theta inhibitor is a selective PKC-θinhibitor, with an IC50 of 12 nM.

  • GC30545 structure
    GC30545Malantide
    CAS: 86555-35-3
    Purity: >98.50%

    Malantide is a synthetic dodecapeptide derived from the site phosphorylated by cAMP-dependent protein kinase (PKA) on the β-subunit of phosphorylase kinase. Malantide is a highly specific substrate for PKA with a Km of 15 μM and shows protein inhibitor (PKI) inhibition >90% substrate phosphorylation in various rat tissue extracts. Malantide is also an efficient substrate for PKC with a Km of 16 μM.

  • GC31656 structure
    GC31656Ingenol Mebutate (Ingenol 3-angelate)
    CAS: 75567-37-2
    Purity: >99.00%

    Ingenol Mebutate (Ingenol 3-angelate) is an active ingredient in Euphorbia peplus, acts as a potent PKC modulator, with Kis of 0.3, 0.105, 0.162, 0.376, and 0.171 nM for PKC-α, PKC-β, PKC-γ, PKC-δ, and PKC-ε, respectively, and has antiinflammatory and antitumor activity.

  • GC31711 structure
    GC31711PKC-IN-1
    CAS: 1046787-18-1
    Purity: >98.50%

    PKC-IN-1 is a potent, ATP-competitive and reversible inhibitor of conventional PKC enzymes with Kis of 5.3 and 10.4 nM for human PKCβ and PKCα, and IC50s of 2.3, 8.1, 7.6, 25.6, 57.5, 314, 808 nM for PKCα, PKCβI, PKCβII, PKCθ, PKCγ, PKC mu and PKCε, respectively.